4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents. 2020

Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
Department of Organic Chemistry, Medical University of Gdańsk, Gdańsk, Poland.

The series of new 4-substituted picolinohydrazonamides were synthesized (6-25) and evaluated for tuberculostatic activity. Compounds having a hydrophilic cyclic amine such as morpholine and pyrrolidine at the end of the thiosemicarbazide chain, exhibited the highest antimycobacterial activity. The antimycobacterial activity of compounds 6, 11, and 15 (MIC 0.4-0.8 μg/mL) was higher than that of reference drugs. Moreover, derivative 15 exhibited lower activity against other tested microorganism such as bacteria gram-positive, gram-negative or fungi. Thus, this compound is characterized by the selectivity of antimicrobial activity. Antiproliferative study conducted against human dermal fibroblasts (HDF) and mouse melanoma cell line (B16-F10) revealed low cytotoxicity of compound 15. Conducted research allowed to identify compound 15 as leading for further research.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013882 Thiosemicarbazones Thiosemicarbazone
D015003 Yeasts A general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED. Yeast
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
October 2010, Bioorganic & medicinal chemistry letters,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
March 1998, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
March 2003, Bioorganic & medicinal chemistry letters,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
October 2012, Bioorganic & medicinal chemistry letters,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
August 2022, Materials (Basel, Switzerland),
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
September 1988, Die Pharmazie,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
September 1985, Ceskoslovenska farmacie,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
January 2020, European journal of medicinal chemistry,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
February 1989, Die Pharmazie,
Malwina Krause, and Henryk Foks, and Dagmara Ziembicka, and Ewa Augustynowicz-Kopeć, and Agnieszka Głogowska, and Izabela Korona-Głowniak, and Krzysztof Bojanowski, and Danuta Siluk, and Katarzyna Gobis
January 1979, Arzneimittel-Forschung,
Copied contents to your clipboard!